/
MIRA
$0.81+$0.07 (+9.61%)live
Change$-6.59
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$35.0M
42M shares
52-week range
$0.60 – $2.45
11% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
MIRA Pharmaceuticals, Inc. Common Stock
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
www.mirapharmaceuticals.com- Employees
- 2
- IPO / List date
- Aug 3, 2023
- HQ
- MIAMI, FL
Held by traders on TradeandTell
No one on the platform currently holds MIRA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 46,700 | $63.5K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MIRA yet.
